progressive supranuclear palsy

Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's
Fierce Biotech
Fri, 12/13/19 - 12:26 pm
Biogen
Alzheimer's disease
aducanumab
progressive supranuclear palsy
gosuranemab
clinical trials
AbbVie scraps an anti-tau study, and that may foretell more big trouble for a beleaguered Biogen
Endpoints
Fri, 07/26/19 - 11:00 am
AbbVie
Biogen
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
Biogen Snaps Up A 'Rare Find' From BMS: Instinet
Barron's
Sat, 04/15/17 - 09:25 am
Biogen
Bristol-Myers Squibb
BMS-986168
progressive supranuclear palsy
FDA grants AbbVie's anti-tau drug orphan status
BioPharma Dive
Mon, 07/20/15 - 11:07 am
FDA
AbbVie
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
C2N Diagnostics